These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 1605610)
1. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats. Catherall EJ; Gillon V; Hurn S; Irwin R; Mizen L Antimicrob Agents Chemother; 1992 Feb; 36(2):458-62. PubMed ID: 1605610 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat. Catherall EJ; Irwin R; Mizen LW J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. Boon RJ; Beale AS; Sutherland R Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. Casey P; Glauser M Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834 [TBL] [Abstract][Full Text] [Related]
5. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates. Barry AL Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775 [TBL] [Abstract][Full Text] [Related]
6. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919 [TBL] [Abstract][Full Text] [Related]
7. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Hirano L; Bayer AS Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374 [TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms. Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813 [TBL] [Abstract][Full Text] [Related]
11. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity. Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032 [TBL] [Abstract][Full Text] [Related]
12. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae. Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630 [TBL] [Abstract][Full Text] [Related]
13. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors. White A; Cooper C; Stokes D Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934 [No Abstract] [Full Text] [Related]
15. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis. Miller WR; Singh KV; Arias CA; Murray BE Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459 [TBL] [Abstract][Full Text] [Related]
16. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Ramos MC; Ing M; Kim E; Witt MD; Bayer AS Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887 [TBL] [Abstract][Full Text] [Related]
17. Ticarcillin-clavulanic acid dosing ratio for treatment of experimental Staphylococcus aureus endocarditis. Goodman JS Antimicrob Agents Chemother; 1992 Jul; 36(7):1585. PubMed ID: 1510459 [No Abstract] [Full Text] [Related]
18. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid. Reed MD Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid. Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Fass RJ; Prior RB Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]